ClinVar Miner

Submissions for variant NM_000071.2(CBS):c.401G>C (p.Gly134Ala) (rs766958673)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000198867 SCV000249681 uncertain significance not provided 2014-01-11 criteria provided, single submitter clinical testing p.Gly134Ala (GGG>GCG): c.401 G>C in exon 5 of the CBS gene (NM_000071.2). The G134A variant in the CBS gene has not been reported as a disease-causing mutation or as a benign polymorphism to our knowledge. The G134 residue is highly conserved across species and in silico analysis predicts G134A is damaging to the protein structure/function. The G134A variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Missense mutations in nearby residues (E128D, E131D, G139R) have been reported in association with homocystinuria, supporting the functional importance of this region of the protein. However, G134A is a conservative amino acid substitution as these residues share similar properties, and are least likely to impact secondary structure. With the clinical and molecular information available at this time, we cannot definitively determine if G134A is a disease-causing mutation or a rare benign variant. This variant was found in TAAD

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.